Pharmacogenomics of opioids and perioperative pain management

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA et al. Pain in children and adolescents: a common experience. Pain87(1),51–58 (2000).
  Medline CASGoogle Scholar
• 2  Hall MJ, Defrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. Natl Health Stat. Report29,1–20, 24 (2007).
  Google Scholar
• 3  Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics118(2),651–658 (2006).
  MedlineGoogle Scholar
• 4  Duedahl TH, Hansen EH. A qualitative systematic review of morphine treatment in children with postoperative pain. Paediatr. Anaesth.17(8),756–774 (2007).
  MedlineGoogle Scholar
• 5  Beaulieu P, Cyrenne L, Mathews S, Villeneuve E, Vischoff D. Patient-controlled analgesia after spinal fusion for idiopathic scoliosis. Int. Orthop.20(5),295–299 (1996).
  Medline CASGoogle Scholar
• 6  Goodman LS, Gilman A, Brunton LL, Lazo JS, Parker KL. Goodman & Gilman’s the Pharmacological Basis of Therapeutics (11th Edition). Brunton LL, Lazo JS, Parker KL (Eds). McGraw-Hill, NY, USA (2006).
  Google Scholar
• 7  Anderson BJ, Palmer GM. Recent pharmacological advances in paediatric analgesics. Biomed. Pharmacother.60(7),303–309 (2006).
  Medline CASGoogle Scholar
• 8  Knaggs RD, Crighton IM, Cobby TF, Fletcher AJ, Hobbs GJ. The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth. Analg.99(1),108–112 (2004).
  Medline CASGoogle Scholar
• 9  Shapiro A, Zohar E, Zaslansky R, Hoppenstein D, Shabat S, Fredman B. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. J. Clin. Anesth.17(7),537–542 (2005).
  Medline CASGoogle Scholar
• 10  Gill AM, Cousins A, Nunn AJ, Choonara IA. Opiate-induced respiratory depression in pediatric patients. Ann. Pharmacother.30(2),125–129 (1996).
  Medline CASGoogle Scholar
• 11  Sachdeva DK, Stadnyk JM. Are one or two dangerous? Opioid exposure in toddlers. J. Emerg. Med.29(1),77–84 (2005).
  MedlineGoogle Scholar
• 12  Monitto CL, Greenberg RS, Kost-Byerly S et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesth. Analg.91(3),573–579 (2000).
  Medline CASGoogle Scholar
• 13  Habre W, McLeod B. Analgesic and respiratory effect of nalbuphine and pethidine for adenotonsillectomy in children with obstructive sleep disorder. Anaesthesia52(11),1101–1106 (1997).
  Medline CASGoogle Scholar
• 14  Aubrun F, Langeron O, Quesnel C, Coriat P, Riou B. Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology98(6),1415–1421 (2003).
  Medline CASGoogle Scholar
• 15  Mazoit JX, Butscher K, Samii K. Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites. Anesth. Analg.105(1),70–78 (2007).
  Medline CASGoogle Scholar
• 16  Pattinson KT. Opioids and the control of respiration. Br. J. Anaesth.100(6),747–758 (2008).
  Medline CASGoogle Scholar
• 17  Oderda GM, Said Q, Evans RS et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann. Pharmacother.41(3),400–406 (2007).
  MedlineGoogle Scholar
• 18  Galley HF, Mahdy A, Lowes DA. Pharmacogenetics and anesthesiologists. Pharmacogenomics6(8),849–856 (2005).
  CASGoogle Scholar
• 19  Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth. Analg.105(1),205–221 (2007).
  MedlineGoogle Scholar
• 20  Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesth. Clin. North Am.23(1),21–36 (2005).
  MedlineGoogle Scholar
• 21  Kim H, Clark D, Dionne RA. Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research. J. Pain10(7),663–693 (2009).
  MedlineGoogle Scholar
• 22  Palmer SN, Giesecke NM, Body SC, Shernan SK, Fox AA, Collard CD. Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology102(3),663–671 (2005).
  Medline CASGoogle Scholar
• 23  Ziegeler S, Tsusaki BE, Collard CD. Influence of genotype on perioperative risk and outcome. Anesthesiology99(1),212–219 (2003).
  MedlineGoogle Scholar
• 24  Finishing the euchromatic sequence of the human genome. Nature431(7011),931–945 (2004).
  MedlineGoogle Scholar
• 25  Kim DH, Dai F, Belfer I et al. Polymorphic variation of the guanosine triphosphate cyclohydrolase 1 gene predicts outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine (Phila. Pa 1976)35(21),1909–1914 (2010).
  MedlineGoogle Scholar
• 26  Bringuier S, Dadure C, Raux O, Dubois A, Picot MC, Capdevila X. The perioperative validity of the visual analog anxiety scale in children: a discriminant and useful instrument in routine clinical practice to optimize postoperative pain management. Anesth. Analg.109(3),737–744 (2009).
  MedlineGoogle Scholar
• 27  Wang DG, Fan JB, Siao CJ et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science280(5366),1077–1082 (1998).
  Medline CASGoogle Scholar
• 28  Atkins JH, Johansson JS. Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine. Anesth. Analg.102(4),1207–1216 (2006).
  Medline CASGoogle Scholar
• 29  Holliday R. Mechanisms for the control of gene activity during development. Biol. Rev. Camb. Philos. Soc.65(4),431–471 (1990).
  Medline CASGoogle Scholar
• 30  Ross JR, Rutter D, Welsh K et al. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J.5(5),324–336 (2005).
  Medline CASGoogle Scholar
• 31  Coderre TJ, Basbaum AI, Dallman MF, Helms C, Levine JD. Epinephrine exacerbates arthritis by an action at presynaptic B2-adrenoceptors. Neuroscience34(2),521–523 (1990).
  Medline CASGoogle Scholar
• 32  Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci.6(12),3423–3429 (1986).
  Medline CASGoogle Scholar
• 33  Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptors. Pain128(3),199–208 (2007).
  Medline CASGoogle Scholar
• 34  Rakvag TT, Klepstad P, Baar C et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain116(1–2),73–78 (2005).
  Medline CASGoogle Scholar
• 35  Wood PB. Mesolimbic dopaminergic mechanisms and pain control. Pain120(3),230–234 (2006).
  Medline CASGoogle Scholar
• 36  Delaney AJ, Crane JW, Sah P. Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism. Neuron56(5),880–892 (2007).
  Medline CASGoogle Scholar
• 37  Mcewen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev.87(3),873–904 (2007).
  MedlineGoogle Scholar
• 38  Khasar SG, Burkham J, Dina OA et al. Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J. Neurosci.28(22),5721–5730 (2008).
  Medline CASGoogle Scholar
• 39  Lotta T, Vidgren J, Tilgmann C et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry34(13),4202–4210 (1995).
  Medline CASGoogle Scholar
• 40  Zubieta JK, Heitzeg MM, Smith YR et al.COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science299(5610),1240–1243 (2003).
  Medline CASGoogle Scholar
• 41  Rakvag TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol. Pain4,64 (2008).
  MedlineGoogle Scholar
• 42  Diatchenko L, Slade GD, Nackley AG et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet.14(1),135–143 (2005).
  Medline CASGoogle Scholar
• 43  Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics6(3),243–250 (1996).
  Medline CASGoogle Scholar
• 44  Kim H, Neubert JK, San Miguel A et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain109(3),488–496 (2004).
  MedlineGoogle Scholar
• 45  Reyes-Gibby CC, Shete S, Rakvag T et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain130(1–2),25–30 (2007).
  Medline CASGoogle Scholar
• 46  Nackley AG, Shabalina SA, Tchivileva IE et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science314(5807),1930–1933 (2006).
  Medline CASGoogle Scholar
• 47  Diatchenko L, Anderson AD, Slade GD et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.141B(5),449–462 (2006).
  Medline CASGoogle Scholar
• 48  Mongini F, Rota E, Evangelista A et al. Personality profiles and subjective perception of pain in head pain patients. Pain144(1–2),125–129 (2009).
  MedlineGoogle Scholar
• 49  Sadhasivam S, Chidambaran V, Ngamprasertwong P et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics129(5),832–838 (2012).▪▪ Prospective perioperative pain and opioid analgesia study in children that highlights the importance of population stratification before associating genotypes with clinical outcomes.
  MedlineGoogle Scholar
• 50  Lee PJ, Delaney P, Keogh J, Sleeman D, Shorten GD. Catecholamine-O-methyltransferase polymorphisms are associated with postoperative pain intensity. Clin. J. Pain27(2),93–101 (2011).
  Medline CASGoogle Scholar
• 51  George SZ, Wallace MR, Wright TW et al. Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings. Pain136(1–2),53–61 (2008).
  Medline CASGoogle Scholar
• 52  Dai F, Belfer I, Schwartz CE et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J.10(11),949–957 (2010).
  MedlineGoogle Scholar
• 53  Henker RA, Lewis A, Dai F et al. The associations between OPRM1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. Biol. Res. Nurs. doi:10.1177/1099800411436171 (2012) (Epub ahead of print).
  Google Scholar
• 54  Hickey OT, Nugent NF, Burke SM, Hafeez P, Mudrakouski AL, Shorten GD. Persistent pain after mastectomy with reconstruction. J. Clin. Anesth.23(6),482–488 (2011).
  MedlineGoogle Scholar
• 55  Latremoliere A, Costigan M. GCH1, BH4 and pain. Curr. Pharm. Biotechnol.12(10),1728–1741 (2011).
  Medline CASGoogle Scholar
• 56  Costigan M, Latremoliere A, Woolf CJ. Analgesia by inhibiting tetrahydrobiopterin synthesis. Curr. Opin. Pharmacol.12(1),92–99 (2012).
  Medline CASGoogle Scholar
• 57  Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit. Care Med.24(3),381–384 (1996).
  Medline CASGoogle Scholar
• 58  Rosczyk HA, Sparkman NL, Johnson RW. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp. Gerontol.43(9),840–846 (2008).
  Medline CASGoogle Scholar
• 59  Giannoudis PV, Dinopoulos H, Chalidis B, Hall GM. Surgical stress response. Injury37(Suppl. 5),S3–S9 (2006).
  MedlineGoogle Scholar
• 60  Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg.75(2),S715–S720 (2003).
  MedlineGoogle Scholar
• 61  Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery127(2),117–126 (2000).
  Medline CASGoogle Scholar
• 62  Wolf G, Livshits D, Beilin B, Yirmiya R, Shavit Y. Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice. Brain Behav. Immun.22(7),1072–1077 (2008).
  Medline CASGoogle Scholar
• 63  Brull DJ, Montgomery HE, Sanders J et al. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscl. Thromb. Vasc. Biol.21(9),1458–1463 (2001).
  Medline CASGoogle Scholar
• 64  Roth-Isigkeit A, Hasselbach L, Ocklitz E et al. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin. Exp. Immunol.125(1),80–88 (2001).
  Medline CASGoogle Scholar
• 65  Mira JP, Cariou A, Grall F et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA282(6),561–568 (1999).
  Medline CASGoogle Scholar
• 66  Hutchinson MR, Coats BD, Lewis SS et al. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immun.22(8),1178–1189 (2008).
  Medline CASGoogle Scholar
• 67  Johnston IN, Milligan ED, Wieseler-Frank J et al. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci.24(33),7353–7365 (2004).
  Medline CASGoogle Scholar
• 68  Candiotti KA, Yang Z, Morris R et al. Polymorphism in the interleukin-1 receptor antagonist gene is associated with serum interleukin-1 receptor antagonist concentrations and postoperative opioid consumption. Anesthesiology114(5),1162–1168 (2011).
  Medline CASGoogle Scholar
• 69  Gelb K, Gelb AW. Sex and gender in the perioperative period: wake up to reality. Anesth. Analg.107(1),1–3 (2008).
  MedlineGoogle Scholar
• 70  Chin ML, Rosenquist R. Sex, gender, and pain: “men are from Mars, women are from venus ..”. Anesth. Analg.107(1),4–5 (2008).
  MedlineGoogle Scholar
• 71  Hurley RW, Adams MC. Sex, gender, and pain: an overview of a complex field. Anesth. Analg.107(1),309–317 (2008).
  MedlineGoogle Scholar
• 72  Hashmi JA, Davis KD. Women experience greater heat pain adaptation and habituation than men. Pain145(3),350–357 (2009).
  MedlineGoogle Scholar
• 73  Dahan A, Kest B, Waxman AR, Sarton E. Sex-specific responses to opiates: animal and human studies. Anesth. Analg.107(1),83–95 (2008).
  Medline CASGoogle Scholar
• 74  Mogil JS, Wilson SG, Chesler EJ et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc. Natl Acad. Sci. USA100(8),4867–4872 (2003).
  Medline CASGoogle Scholar
• 75  Sarton E, Olofsen E, Romberg R et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology93(5),1245–1254; discussion 1246A (2000).
  Medline CASGoogle Scholar
• 76  Keogh E, Herdenfeldt M. Gender, coping and the perception of pain. Pain97(3),195–201 (2002).
  MedlineGoogle Scholar
• 77  Edwards RR, Doleys DM, Fillingim RB, Lowery D. Ethnic differences in pain tolerance: clinical implications in a chronic pain population. Psychosom. Med.63(2),316–323 (2001).
  Medline CASGoogle Scholar
• 78  Edwards RR, Moric M, Husfeldt B, Buvanendran A, Ivankovich O. Ethnic similarities and differences in the chronic pain experience: a comparison of African American, Hispanic, and white patients. Pain Med.6(1),88–98 (2005).
  MedlineGoogle Scholar
• 79  Rahim-Williams FB, Riley JL, Herrera D, Campbell CM, Hastie BA, Fillingim RB. Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain129(1–2),177–184 (2007).
  MedlineGoogle Scholar
• 80  Ng B, Dimsdale JE, Rollnik JD, Shapiro H. The effect of ethnicity on prescriptions for patient-controlled analgesia for post-operative pain. Pain66(1),9–12 (1996).
  Medline CASGoogle Scholar
• 81  Crowley JJ, Oslin DW, Patkar AA et al. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr. Genet.13(3),169–173 (2003).
  MedlineGoogle Scholar
• 82  Ikeda K, Ide S, Han W, Hayashida M, Uhl GR, Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol. Sci.26(6),311–317 (2005).
  Medline CASGoogle Scholar
• 83  Bond C, Laforge KS, Tian M et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl Acad. Sci. USA95(16),9608–9613 (1998).
  Medline CASGoogle Scholar
• 84  Bergen AW, Kokoszka J, Peterson R et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry2(6),490–494 (1997).
  Medline CASGoogle Scholar
• 85  Gelernter J, Kranzler H, Cubells J. Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol. Psychiatry4(5),476–483 (1999).
  Medline CASGoogle Scholar
• 86  Johansen A, Romundstad L, Nielsen CS, Schirmer H, Stubhaug A. Persistent postsurgical pain in a general population: Prevalence and predictors in the Tromsø study. Pain153(7),1390–1396 (2012).
  MedlineGoogle Scholar
• 87  Peters ML, Sommer M, Van Kleef M, Marcus MA. Predictors of physical and emotional recovery 6 and 12 months after surgery. Br. J. Surg.97(10),1518–1527 (2010).
  Medline CASGoogle Scholar
• 88  Khan RS, Ahmed K, Blakeway E et al. Catastrophizing: a predictive factor for postoperative pain. Am. J. Surg.201(1),122–131 (2011).
  MedlineGoogle Scholar
• 89  Kain ZN, Caldwell-Andrews AA, Krivutza DM, Weinberg ME, Wang SM, Gaal D. Trends in the practice of parental presence during induction of anesthesia and the use of preoperative sedative premedication in the United States, 1995–2002: results of a follow-up national survey. Anesth. Analg.98(5),1252–1259, table of contents (2004).
  MedlineGoogle Scholar
• 90  Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H. COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain152(2),300–307 (2011).
  MedlineGoogle Scholar
• 91  Caldas JC, Pais-Ribeiro JL, Carneiro SR. General anesthesia, surgery and hospitalization in children and their effects upon cognitive, academic, emotional and sociobehavioral development – a review. Paediatr. Anaesth.14(11),910–915 (2004).
  MedlineGoogle Scholar
• 92  Mcgraw T. Preparing children for the operating room: psychological issues. Can. J. Anaesth.41(11),1094–1103 (1994).
  Medline CASGoogle Scholar
• 93  Wildgaard K, Ringsted TK, Aasvang EK, Ravn J, Werner MU, Kehlet H. Neurophysiological characterization of persistent postthoracotomy pain. Clin. J. Pain28(2),136–142 (2012).
  MedlineGoogle Scholar
• 94  Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet367(9522),1618–1625 (2006).
  MedlineGoogle Scholar
• 95  Uhl GR, Sora I, Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl Acad. Sci. USA96(14),7752–7755 (1999).
  Medline CASGoogle Scholar
• 96  Lotsch J, Geisslinger G. Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol. Med.11(2),82–89 (2005).
  MedlineGoogle Scholar
• 97  Lotsch J, Skarke C, Grosch S, Darimont J, Schmidt H, Geisslinger G. The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics12(1),3–9 (2002).
  Medline CASGoogle Scholar
• 98  Oertel BG, Schmidt R, Schneider A, Geisslinger G, Lotsch J. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet. Genomics16(9),625–636 (2006).
  Medline CASGoogle Scholar
• 99  Somogyi AA, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin. Pharmacol. Ther.81(3),429–444 (2007).
  Medline CASGoogle Scholar
• 100  Angst MS, Lazzeroni LC, Phillips NG et al. Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology117(1),22–37 (2012).▪▪ Opioid pharmacogenetic twins study that demonstrated significant genetic effects for opioid-related respiratory depression, dislining and nausea.
  Medline CASGoogle Scholar
• 101  Chou WY, Yang LC, Lu HF et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol. Scand.50(7),787–792 (2006).
  Medline CASGoogle Scholar
• 102  Wang D, Quillan JM, Winans K, Lucas JL, Sadee W. Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding. J. Biol. Chem.276(37),34624–34630 (2001).
  Medline CASGoogle Scholar
• 103  Romberg RR, Olofsen E, Bijl H et al. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology102(3),522–530 (2005).
  Medline CASGoogle Scholar
• 104  Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology105(2),334–337 (2006).
  Medline CASGoogle Scholar
• 105  Janicki PK, Schuler G, Francis D et al. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth. Analg.103(4),1011–1017 (2006).
  Medline CASGoogle Scholar
• 106  Coulbault L, Beaussier M, Verstuyft C et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin. Pharmacol. Ther.79(4),316–324 (2006).
  Medline CASGoogle Scholar
• 107  Walter C, Lotsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain146(3),270–275 (2009).
  Medline CASGoogle Scholar
• 108  Ginosar Y, Davidson EM, Meroz Y, Blotnick S, Shacham M, Caraco Y. Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study. Br. J. Anaesth.103(3),420–427 (2009).
  Medline CASGoogle Scholar
• 109  Ochroch EA, Vachani A, Gottschalk A, Kanetsky PA. Natural variation in the mu-opioid gene OPRM1 predicts increased pain on third day after thoracotomy. Clin. J. Pain28(9),747–754 (2011).
  Google Scholar
• 110  Mogil JS, Ritchie J, Smith SB et al. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J. Med. Genet.42(7),583–587 (2005).
  Medline CASGoogle Scholar
• 111  Manzke T, Guenther U, Ponimaskin EG et al. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science301(5630),226–229 (2003).
  Medline CASGoogle Scholar
• 112  Nishizawa D, Nagashima M, Katoh R et al. Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS One4(9),E7060 (2009).
  MedlineGoogle Scholar
• 113  Smith HS. Opioid metabolism. Mayo Clin. Proc.84(7),613–624 (2009).
  Medline CASGoogle Scholar
• 114  Dayer P, Desmeules J, Leemann T, Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem. Biophys. Res. Commun.152(1),411–416 (1988).
  Medline CASGoogle Scholar
• 115  Caraco Y, Sheller J, Wood AJ. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions. J. Pharmacol. Exp. Ther.278(3),1165–1174 (1996).
  Medline CASGoogle Scholar
• 116  Lalovic B, Phillips B, Risler LL, Howald W, Shen DD. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab. Dispos.32(4),447–454 (2004).
  Medline CASGoogle Scholar
• 117  McEwan A, Sigston PE, Andrews KA et al. A comparison of rectal and intramuscular codeine phosphate in children following neurosurgery. Paediatr. Anaesth.10(2),189–193 (2000).
  Medline CASGoogle Scholar
• 118  Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br. J. Anaesth.89(6),839–845 (2002).
  Medline CASGoogle Scholar
• 119  Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn. Schmiedebergs. Arch. Pharmacol.369(1),23–37 (2004).
  Medline CASGoogle Scholar
• 120  Gaedigk A, Ryder DL, Bradford LD, Leeder JS. CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism. Clin. Chem.49(6 Pt 1),1008–1011 (2003).
  Medline CASGoogle Scholar
• 121  Raimundo S, Fischer J, Eichelbaum M, Griese EU, Schwab M, Zanger UM. Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6. Pharmacogenetics10(7),577–581 (2000).
  Medline CASGoogle Scholar
• 122  Heller T, Kirchheiner J, Armstrong VW et al. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther. Drug. Monit.28(5),673–677 (2006).
  Medline CASGoogle Scholar
• 123  Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics3(2),229–243 (2002).
  CASGoogle Scholar
• 124  Poulsen L, Brosen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur. J. Clin. Pharmacol.51(3–4),289–295 (1996).
  Medline CASGoogle Scholar
• 125  Lotsch J, Skarke C, Schmidt H et al. Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites. Clin. Pharmacol. Ther.79(1),35–48 (2006).
  MedlineGoogle Scholar
• 126  Gaedigk A, Ndjountche L, Divakaran K et al. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin. Pharmacol. Ther.81(2),242–251 (2007).
  Medline CASGoogle Scholar
• 127  Lundqvist E, Johansson I, Ingelman-Sundberg M. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene226(2),327–338 (1999).
  Medline CASGoogle Scholar
• 128  Bernard S, Neville KA, Nguyen AT, Flockhart DA. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist11(2),126–135 (2006).
  Medline CASGoogle Scholar
• 129  Shipton EA, Muller FO, Herhold WJ, De Vaal JB. Ingestion of codeine and salicylic acid causing convulsions and coma. A case report. S. Afr. Med. J.66(12),460 (1984).
  Medline CASGoogle Scholar
• 130  Kintz P, Tracqui A, Mangin P. Codeine concentrations in human samples in a case of fatal ingestion. Int. J. Legal Med.104(3),177–178 (1991).
  Medline CASGoogle Scholar
• 131  Magnani B, Evans R. Codeine intoxication in the neonate. Pediatrics104(6),e75 (1999).
  Medline CASGoogle Scholar
• 132  Voronov P, Przybylo HJ, Jagannathan N. Apnea in a child after oral codeine: a genetic variant – an ultra-rapid metabolizer. Paediatr. Anaesth.17(7),684–687 (2007).
  MedlineGoogle Scholar
• 133  Voronov P. Codeine induced respiratory depression in a child: Author’s reply. Paediatr. Anaesth.18(3),273–274 (2008).
  MedlineGoogle Scholar
• 134  Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G. Codeine, ultrarapid-metabolism genotype, and postoperative death. N. Engl. J. Med.361(8),827–828 (2009).
  Medline CASGoogle Scholar
• 135  Hermanns-Clausen M, Weinmann W, Auwarter V et al. Drug dosing error with drops: severe clinical course of codeine intoxication in twins. Eur. J. Pediatr.168(7),819–824 (2009).
  MedlineGoogle Scholar
• 136  Kelly L, Rieder M, van den Anker J et al. More codeine fatalities after tonsillectomy in north American children. Pediatrics129(5),e1343–e1347 (2012).
  MedlineGoogle Scholar
• 137  Sadhasivam S, Myer CM 3rd. Preventing opioid-related deaths in children undergoing surgery. Pain Med.13(7),982–983 (2012).▪ Highlights importance of genetic variations contributing to opioid-related deaths and the need to change current clinical practice.
  MedlineGoogle Scholar
• 138  Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet368(9536),704 (2006).
  MedlineGoogle Scholar
• 139  Gan SH, Ismail R, Wan Adnan WA, Zulmi W. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics. Mol. Diag. Ther.11(3),171–181 (2007).
  Medline CASGoogle Scholar
• 140  Otton SV, Schadel M, Cheung SW, Kaplan HL, Busto UE, Sellers EM. CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clin. Pharmacol. Ther.54(5),463–472 (1993).
  Medline CASGoogle Scholar
• 141  Smith HS. The metabolism of opioid agents and the clinical impact of their active metabolites. Clin. J. Pain27(9),824–838 (2011).▪ Good review of metabolism of opioids and the clinical impact of genetic variability on metabolites.
  MedlineGoogle Scholar
• 142  Zwisler ST, Enggaard TP, Noehr-Jensen L et al. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. Basic Clin. Pharmacol. Toxicol.104(4),335–344 (2009).
  Medline CASGoogle Scholar
• 143  Gillen C, Haurand M, Kobelt DJ, Wnendt S. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedeberg’s Arch. Pharmacol.362(2),116–121 (2000).
  Medline CASGoogle Scholar
• 144  Stamer UM, Lehnen K, Hothker F et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain105(1–2),231–238 (2003).
  Medline CASGoogle Scholar
• 145  Zwisler ST, Enggaard TP, Mikkelsen S, Brosen K, Sindrup SH. Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia. Acta Anaesthesiol. Scand.54(2),232–240 (2010).
  Medline CASGoogle Scholar
• 146  Crews KR, Gaedigk A, Dunnenberger HM et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin. Pharmacol. Ther.91(2),321–326 (2012).▪▪ Recent Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines outline when to use and avoid codeine based on CYP2D6 genotype.
  Medline CASGoogle Scholar
• 147  Holthe M, Rakvag TN, Klepstad P et al. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J.3(1),17–26 (2003).
  Medline CASGoogle Scholar
• 148  Sawyer MB, Innocenti F, Das S et al. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin. Pharmacol. Ther.73(6),566–574 (2003).
  Medline CASGoogle Scholar
• 149  Fujita KI, Ando Y, Yamamoto W et al. Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother. Pharmacol.65(2),251–258 (2010).
  Medline CASGoogle Scholar
• 150  Saito K, Moriya H, Sawaguchi T et al. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects. Clin. Biochem.39(3),303–308 (2006).
  Medline CASGoogle Scholar
• 151  Sadhasivam S, Krekels EHJ, Chidambaran V et al. Morphine clearance in children: does race or genetics matter? J. Opioid Manag.8(4),217–226 (2012).
  MedlineGoogle Scholar
• 152  Chakravarti A. Being human: kinship: race relations. Nature457(7228),380–381 (2009).
  Medline CASGoogle Scholar
• 153  Rahemtulla T, Bhopal R. Pharmacogenetics and ethnically targeted therapies. BMJ330(7499),1036–1037 (2005).
  MedlineGoogle Scholar
• 154  Bhopal R. Glossary of terms relating to ethnicity and race: for reflection and debate. J. Epidemiol. Community Health58(6),441–445 (2004).
  Medline CASGoogle Scholar
• 155  Shastry BS. Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J.6(1),16–21 (2006).
  Medline CASGoogle Scholar
• 156  Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol. Ther.112(2),457–473 (2006).
  Medline CASGoogle Scholar
• 157  Tournier N, Decleves X, Saubamea B, Scherrmann JM, Cisternino S. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology. Curr. Pharm. Des.17(26),2829–2842 (2011).
  Medline CASGoogle Scholar
• 158  Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci.25(8),423–429 (2004).
  Medline CASGoogle Scholar
• 159  Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta455(1),152–162 (1976).
  Medline CASGoogle Scholar
• 160  Juranka PF, Zastawny RL, Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J.3(14),2583–2592 (1989).
  Medline CASGoogle Scholar
• 161  Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin. Pharmacol. Ther.80(6),682–690 (2006).
  Medline CASGoogle Scholar
• 162  Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet. Genomics15(10),693–704 (2005).
  Medline CASGoogle Scholar
• 163  Ameyaw MM, Regateiro F, Li T et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics11(3),217–221 (2001).
  Medline CASGoogle Scholar
• 164  Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin. Pharmacol. Ther.83(4),559–566 (2008).
  Medline CASGoogle Scholar
• 165  Park HJ, Shinn HK, Ryu SH, Lee HS, Park CS, Kang JH. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin. Pharmacol. Ther.81(4),539–546 (2007).
  Medline CASGoogle Scholar
• 166  Kim RB, Leake BF, Choo EF et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther.70(2),189–199 (2001).
  Medline CASGoogle Scholar
• 167  Kimchi-Sarfaty C, Marple AH, Shinar S et al. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics8(1),29–39 (2007).
  CASGoogle Scholar
• 168  Kolesnikov Y, Gabovits B, Levin A, Voiko E, Veske A. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. Anesth. Analg.112(2),448–453 (2011).▪ This morphine pharmacogenetic study demonstrated the importance of the gene–gene approach.
  Medline CASGoogle Scholar
• 169  Zwisler ST, Enggaard TP, Noehr-Jensen L et al. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes. Fundam. Clin. Pharmacol.24(4),517–524 (2010).
  Medline CASGoogle Scholar
• 170  Zwisler ST, Enggaard TP, Mikkelsen S et al. Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain. J. Clin. Pharmacol.52,234–242 (2012).
  Medline CASGoogle Scholar
• 171  Ratain MJ. Personalized medicine: building the GPS to take us there. Clin. Pharmacol. Ther.81(3),321–322 (2007).
  Medline CASGoogle Scholar
• 172  Lötsch J, Geisslinger G. Current evidence for a genetic modulation of the response to analgesics. Pain121(1–2),1–5 (2006).
  MedlineGoogle Scholar
• 173  Argoff CE. Clinical implications of opioid pharmacogenetics. Clin. J. Pain.26(Suppl. 10),S16–S20 (2010).
  MedlineGoogle Scholar
• 174  Ioannidis JP, Boffetta P, Little J et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol.37(1),120–132 (2008).
  MedlineGoogle Scholar
• 175  Swen JJ, Wilting I, De Goede AL et al. Pharmacogenetics: from bench to byte. Clin. Pharmacol. Ther.83(5),781–787 (2008).
  Medline CASGoogle Scholar
• 176  Sia AT, Lim Y, Lim EC et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology109(3),520–526 (2008).
  Medline CASGoogle Scholar
• 177  Fukuda K, Hayashida M, Ide S et al. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain147(1–3),194–201 (2009).
  Medline CASGoogle Scholar
• 178  Landau R, Kern C, Columb MO, Smiley RM, Blouin JL. Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain139(1),5–14 (2008).
  Medline CASGoogle Scholar
• 179  Sery O, Hrazdilova O, Didden W et al. The association of monoamine oxidase B functional polymorphism with postoperative pain intensity. Neuro Endocrinol. Lett.27(3),333–337 (2006).
  Medline CASGoogle Scholar
• 180  Kim H, Lee H, Rowan J, Brahim J, Dionne RA. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Mol. Pain2,24 (2006).
  MedlineGoogle Scholar
• 181  Bessler H, Shavit Y, Mayburd E, Smirnov G, Beilin B. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1β and IL-1 receptor antagonist. Neurosci. Lett.404(1–2),154–158 (2006).
  Medline CASGoogle Scholar
• 201  CYP2D6 allele nomenclature. www.cypalleles.ki.se/cyp2d6.htm
  Google Scholar
• 202  US FDA Warning on Codeine Use by Nursing Mothers. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108968.htm
  Google Scholar
• 203  US FDA: FDA Drug Safety Communication: codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. www.fda.gov/drugs/drugsafety/ucm313631.htm
  Google Scholar